Table of Content 1 Spinal Muscular Atrophy Medicine Market Overview 1.1 Product Overview and Scope of Spinal Muscular Atrophy Medicine 1.2 Spinal Muscular Atrophy Medicine Segment by Type 1.2.1 Global Spinal Muscular Atrophy Medicine Sales and CAGR (%) Comparison by Type (2017-2029) 1.2.2 The Market Profile of Spinraza 1.2.3 The Market Profile of RG6083 (Olesoxime) 1.2.4 The Market Profile of RG7916 1.3 Global Spinal Muscular Atrophy Medicine Segment by Application 1.3.1 Spinal Muscular Atrophy Medicine Consumption (Sales) Comparison by Application (2017-2029) 1.3.2 The Market Profile of Oral 1.3.3 The Market Profile of Intrathecal 1.4 Global Spinal Muscular Atrophy Medicine Market, Region Wise (2017-2022) 1.4.1 Global Spinal Muscular Atrophy Medicine Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2022) 1.4.2 United States Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.3 Europe Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.3.1 Germany Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.3.2 UK Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.3.3 France Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.3.4 Italy Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.3.5 Spain Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.3.6 Russia Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.3.7 Poland Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.4 China Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.5 Japan Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.6 India Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.7 Southeast Asia Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.7.1 Malaysia Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.7.2 Singapore Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.7.3 Philippines Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.7.4 Indonesia Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.7.5 Thailand Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.7.6 Vietnam Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.8 Latin America Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.8.1 Brazil Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.8.2 Mexico Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.8.3 Colombia Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.9 Middle East and Africa Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.9.1 Saudi Arabia Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.9.2 United Arab Emirates Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.9.3 Turkey Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.9.4 Egypt Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.9.5 South Africa Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.4.9.6 Nigeria Spinal Muscular Atrophy Medicine Market Status and Prospect (2017-2022) 1.5 Global Market Size of Spinal Muscular Atrophy Medicine (2017-2029) 1.5.1 Global Spinal Muscular Atrophy Medicine Revenue Status and Outlook (2017-2029) 1.5.2 Global Spinal Muscular Atrophy Medicine Sales Status and Outlook (2017-2029) 2 Global Spinal Muscular Atrophy Medicine Market Landscape by Player 2.1 Global Spinal Muscular Atrophy Medicine Sales and Share by Player (2017-2022) 2.2 Global Spinal Muscular Atrophy Medicine Revenue and Market Share by Player (2017-2022) 2.3 Global Spinal Muscular Atrophy Medicine Average Price by Player (2017-2022) 2.4 Global Spinal Muscular Atrophy Medicine Gross Margin by Player (2017-2022) 2.5 Spinal Muscular Atrophy Medicine Manufacturing Base Distribution, Sales Area and Product Type by Player 2.6 Spinal Muscular Atrophy Medicine Market Competitive Situation and Trends 2.6.1 Spinal Muscular Atrophy Medicine Market Concentration Rate 2.6.2 Spinal Muscular Atrophy Medicine Market Share of Top 3 and Top 6 Players 2.6.3 Mergers & Acquisitions, Expansion 3 Spinal Muscular Atrophy Medicine Upstream and Downstream Analysis 3.1 Spinal Muscular Atrophy Medicine Industrial Chain Analysis 3.2 Key Raw Materials Suppliers and Price Analysis 3.3 Key Raw Materials Supply and Demand Analysis 3.4 Manufacturing Process Analysis 3.5 Market Concentration Rate of Raw Materials 3.6 Downstream Buyers 3.7 Value Chain Status Under COVID-18 4 Spinal Muscular Atrophy Medicine Manufacturing Cost Analysis 4.1 Manufacturing Cost Structure Analysis 4.2 Spinal Muscular Atrophy Medicine Key Raw Materials Cost Analysis 4.2.1 Key Raw Materials Introduction 4.2.2 Price Trend of Key Raw Materials 4.3 Labor Cost Analysis 4.3.1 Labor Cost of Spinal Muscular Atrophy Medicine Under COVID-19 4.4 Energy Costs Analysis 4.5 R&D Costs Analysis 5 Market Dynamics 5.1 Drivers 5.2 Restraints and Challenges 5.3 Opportunities 5.3.1 Advances in Innovation and Technology for Spinal Muscular Atrophy Medicine 5.3.2 Increased Demand in Emerging Markets 5.4 Spinal Muscular Atrophy Medicine Industry Development Trends under COVID-19 Outbreak 5.4.1 Global COVID-19 Status Overview 5.4.2 Influence of COVID-19 Outbreak on Spinal Muscular Atrophy Medicine Industry Development 5.5 Consumer Behavior Analysis 6 Players Profiles 6.1 Ionis Pharmaceuticals, Inc. 6.1.1 Ionis Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors 6.1.2 Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification 6.1.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Market Performance (2017-2022) 6.1.4 Ionis Pharmaceuticals, Inc. Business Overview 6.2 Cytokinetics, Inc. 6.2.1 Cytokinetics, Inc. Basic Information, Manufacturing Base, Sales Area and Competitors 6.2.2 Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification 6.2.3 Cytokinetics, Inc. Spinal Muscular Atrophy Medicine Market Performance (2017-2022) 6.2.4 Cytokinetics, Inc. Business Overview 6.3 AveXis, Inc. (Novartis AG) 6.3.1 AveXis, Inc. (Novartis AG) Basic Information, Manufacturing Base, Sales Area and Competitors 6.3.2 Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification 6.3.3 AveXis, Inc. (Novartis AG) Spinal Muscular Atrophy Medicine Market Performance (2017-2022) 6.3.4 AveXis, Inc. (Novartis AG) Business Overview 6.4 F. Hoffmann-La Roche AG 6.4.1 F. Hoffmann-La Roche AG Basic Information, Manufacturing Base, Sales Area and Competitors 6.4.2 Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification 6.4.3 F. Hoffmann-La Roche AG Spinal Muscular Atrophy Medicine Market Performance (2017-2022) 6.4.4 F. Hoffmann-La Roche AG Business Overview 6.5 Biogen Inc. 6.5.1 Biogen Inc. Basic Information, Manufacturing Base, Sales Area and Competitors 6.5.2 Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification 6.5.3 Biogen Inc. Spinal Muscular Atrophy Medicine Market Performance (2017-2022) 6.5.4 Biogen Inc. Business Overview 7 Global Spinal Muscular Atrophy Medicine Sales and Revenue Region Wise (2017-2022) 7.1 Global Spinal Muscular Atrophy Medicine Sales and Market Share, Region Wise (2017-2022) 7.2 Global Spinal Muscular Atrophy Medicine Revenue (Revenue) and Market Share, Region Wise (2017-2022) 7.3 Global Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.4 United States Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.4.1 United States Spinal Muscular Atrophy Medicine Market Under COVID-19 7.5 Europe Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.5.1 Europe Spinal Muscular Atrophy Medicine Market Under COVID-19 7.6 China Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.6.1 China Spinal Muscular Atrophy Medicine Market Under COVID-19 7.7 Japan Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.7.1 Japan Spinal Muscular Atrophy Medicine Market Under COVID-19 7.8 India Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.8.1 India Spinal Muscular Atrophy Medicine Market Under COVID-19 7.9 Southeast Asia Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.9.1 Southeast Asia Spinal Muscular Atrophy Medicine Market Under COVID-19 7.10 Latin America Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.10.1 Latin America Spinal Muscular Atrophy Medicine Market Under COVID-19 7.11 Middle East and Africa Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) 7.11.1 Middle East and Africa Spinal Muscular Atrophy Medicine Market Under COVID-19 8 Global Spinal Muscular Atrophy Medicine Sales, Revenue (Revenue), Price Trend by Type 8.1 Global Spinal Muscular Atrophy Medicine Sales and Market Share by Type (2017-2022) 8.2 Global Spinal Muscular Atrophy Medicine Revenue and Market Share by Type (2017-2022) 8.3 Global Spinal Muscular Atrophy Medicine Price by Type (2017-2022) 8.4 Global Spinal Muscular Atrophy Medicine Sales Growth Rate by Type (2017-2022) 8.4.1 Global Spinal Muscular Atrophy Medicine Sales Growth Rate of Spinraza (2017-2022) 8.4.2 Global Spinal Muscular Atrophy Medicine Sales Growth Rate of RG6083 (Olesoxime) (2017-2022) 8.4.3 Global Spinal Muscular Atrophy Medicine Sales Growth Rate of RG7916 (2017-2022) 9 Global Spinal Muscular Atrophy Medicine Market Analysis by Application 9.1 Global Spinal Muscular Atrophy Medicine Consumption and Market Share by Application (2017-2022) 9.2 Global Spinal Muscular Atrophy Medicine Consumption Growth Rate by Application (2017-2022) 9.2.1 Global Spinal Muscular Atrophy Medicine Consumption Growth Rate of Oral (2017-2022) 9.2.2 Global Spinal Muscular Atrophy Medicine Consumption Growth Rate of Intrathecal (2017-2022) 10 Global Spinal Muscular Atrophy Medicine Market Forecast (2022-2029) 10.1 Global Spinal Muscular Atrophy Medicine Sales, Revenue Forecast (2022-2029) 10.1.1 Global Spinal Muscular Atrophy Medicine Sales and Growth Rate Forecast (2022-2029) 10.1.2 Global Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2022-2029) 10.1.3 Global Spinal Muscular Atrophy Medicine Price and Trend Forecast (2022-2029) 10.2 Global Spinal Muscular Atrophy Medicine Sales and Revenue Forecast, Region Wise (2022-2029) 10.2.1 United States Spinal Muscular Atrophy Medicine Sales and Revenue Forecast (2022-2029) 10.2.2 Europe Spinal Muscular Atrophy Medicine Sales and Revenue Forecast (2022-2029) 10.2.3 China Spinal Muscular Atrophy Medicine Sales and Revenue Forecast (2022-2029) 10.2.4 Japan Spinal Muscular Atrophy Medicine Sales and Revenue Forecast (2022-2029) 10.2.5 India Spinal Muscular Atrophy Medicine Sales and Revenue Forecast (2022-2029) 10.2.6 Southeast Asia Spinal Muscular Atrophy Medicine Sales and Revenue Forecast (2022-2029) 10.2.7 Latin America Spinal Muscular Atrophy Medicine Sales and Revenue Forecast (2022-2029) 10.2.8 Middle East and Africa Spinal Muscular Atrophy Medicine Sales and Revenue Forecast (2022-2029) 10.3 Global Spinal Muscular Atrophy Medicine Sales, Revenue and Price Forecast by Type (2022-2029) 10.4 Global Spinal Muscular Atrophy Medicine Consumption Forecast by Application (2022-2029) 10.5 Spinal Muscular Atrophy Medicine Market Forecast Under COVID-19 11 Research Findings and Conclusion 12 Appendix 12.1 Methodology 12.2 Research Data Source

List of Tables and Figures Figure Spinal Muscular Atrophy Medicine Product Picture Table Global Spinal Muscular Atrophy Medicine Sales and CAGR (%) Comparison by Type Table Profile of Spinraza Table Profile of RG6083 (Olesoxime) Table Profile of RG7916 Table Spinal Muscular Atrophy Medicine Consumption (Sales) Comparison by Application (2017-2029) Table Profile of Oral Table Profile of Intrathecal Figure Global Spinal Muscular Atrophy Medicine Market Size (Revenue) and CAGR (%) (2017-2022) Figure United States Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Europe Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Germany Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure UK Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure France Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Italy Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Spain Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Russia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Poland Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure China Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Japan Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure India Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Malaysia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Singapore Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Philippines Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Indonesia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Thailand Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Vietnam Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Latin America Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Brazil Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Mexico Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Colombia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Middle East and Africa Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Saudi Arabia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure United Arab Emirates Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Turkey Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Egypt Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure South Africa Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Nigeria Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales Status and Outlook (2017-2029) Table Global Spinal Muscular Atrophy Medicine Sales by Player (2017-2022) Table Global Spinal Muscular Atrophy Medicine Sales Share by Player (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales Share by Player in 2021 Table Spinal Muscular Atrophy Medicine Revenue by Player (2017-2022) Table Spinal Muscular Atrophy Medicine Revenue Market Share by Player (2017-2022) Table Spinal Muscular Atrophy Medicine Price by Player (2017-2022) Table Spinal Muscular Atrophy Medicine Gross Margin by Player (2017-2022) Table Spinal Muscular Atrophy Medicine Manufacturing Base Distribution and Sales Area by Player Table Spinal Muscular Atrophy Medicine Product Type by Player Table Mergers & Acquisitions, Expansion Plans Figure Spinal Muscular Atrophy Medicine Industrial Chain Analysis Table Key Raw Materials Suppliers and Price Analysis Figure Market Concentration Rate of Raw Materials Table Downstream Buyers Figure Manufacturing Cost Structure Analysis Table Key Raw Materials Introduction of Spinal Muscular Atrophy Medicine Figure Price Trend of Key Raw Materials Figure Global COVID-19 Status Overview Table Influence of COVID-19 Outbreak on Spinal Muscular Atrophy Medicine Industry Development Table Ionis Pharmaceuticals, Inc. Profile Table Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Figure Ionis Pharmaceuticals, Inc. Revenue and Growth Rate Figure Ionis Pharmaceuticals, Inc. Revenue Market Share 2017-2022 Table Cytokinetics, Inc. Profile Table Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification Table Cytokinetics, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Figure Cytokinetics, Inc. Revenue and Growth Rate Figure Cytokinetics, Inc. Revenue Market Share 2017-2022 Table AveXis, Inc. (Novartis AG) Profile Table Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification Table AveXis, Inc. (Novartis AG) Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Figure AveXis, Inc. (Novartis AG) Revenue and Growth Rate Figure AveXis, Inc. (Novartis AG) Revenue Market Share 2017-2022 Table F. Hoffmann-La Roche AG Profile Table Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification Table F. Hoffmann-La Roche AG Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Figure F. Hoffmann-La Roche AG Revenue and Growth Rate Figure F. Hoffmann-La Roche AG Revenue Market Share 2017-2022 Table Biogen Inc. Profile Table Spinal Muscular Atrophy Medicine Product Profiles, Application and Specification Table Biogen Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Figure Biogen Inc. Revenue and Growth Rate Figure Biogen Inc. Revenue Market Share 2017-2022 Table Global Spinal Muscular Atrophy Medicine Sales, Region Wise (2017-2022) Table Global Spinal Muscular Atrophy Medicine Sales Market Share, Region Wise (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales Market Share, Region Wise (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales Market Share, Region Wise in 2021 Table Global Spinal Muscular Atrophy Medicine Revenue, Region Wise (2017-2022) Table Global Spinal Muscular Atrophy Medicine Revenue Market Share, Region Wise (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share, Region Wise (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share, Region Wise in 2021 Table Global Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table United States Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table Europe Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table China Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table Japan Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table India Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table Southeast Asia Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table Latin America Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table Middle East and Africa Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2017-2022) Table Global Spinal Muscular Atrophy Medicine Sales by Type (2017-2022) Table Global Spinal Muscular Atrophy Medicine Sales Market Share by Type (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales Market Share by Type in 2022 Table Global Spinal Muscular Atrophy Medicine Revenue by Type (2017-2022) Table Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Revenue Market Share by Type in 2022 Table Spinal Muscular Atrophy Medicine Price by Type (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales Growth Rate of Spinraza (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales Growth Rate of RG6083 (Olesoxime) (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales Growth Rate of RG7916 (2017-2022) Table Global Spinal Muscular Atrophy Medicine Consumption by Application (2017-2022) Table Global Spinal Muscular Atrophy Medicine Consumption Market Share by Application (2017-2022) Table Global Spinal Muscular Atrophy Medicine Consumption of Oral (2017-2022) Table Global Spinal Muscular Atrophy Medicine Consumption of Intrathecal (2017-2022) Figure Global Spinal Muscular Atrophy Medicine Sales and Growth Rate Forecast (2022-2029) Figure Global Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2022-2029) Figure Global Spinal Muscular Atrophy Medicine Price and Trend Forecast (2022-2029) Figure USA Spinal Muscular Atrophy Medicine Market Sales and Growth Rate Forecast Analysis (2022-2029) Figure USA Spinal Muscular Atrophy Medicine Market Revenue and Growth Rate Forecast Analysis (2022-2029) Figure Europe Spinal Muscular Atrophy Medicine Market Sales and Growth Rate Forecast Analysis (2022-2029) Figure Europe Spinal Muscular Atrophy Medicine Market Revenue and Growth Rate Forecast Analysis (2022-2029) Figure China Spinal Muscular Atrophy Medicine Market Sales and Growth Rate Forecast Analysis (2022-2029) Figure China Spinal Muscular Atrophy Medicine Market Revenue and Growth Rate Forecast Analysis (2022-2029) Figure Japan Spinal Muscular Atrophy Medicine Market Sales and Growth Rate Forecast Analysis (2022-2029) Figure Japan Spinal Muscular Atrophy Medicine Market Revenue and Growth Rate Forecast Analysis (2022-2029) Figure India Spinal Muscular Atrophy Medicine Market Sales and Growth Rate Forecast Analysis (2022-2029) Figure India Spinal Muscular Atrophy Medicine Market Revenue and Growth Rate Forecast Analysis (2022-2029) Figure Southeast Asia Spinal Muscular Atrophy Medicine Market Sales and Growth Rate Forecast Analysis (2022-2029) Figure Southeast Asia Spinal Muscular Atrophy Medicine Market Revenue and Growth Rate Forecast Analysis (2022-2029) Figure Latin America Spinal Muscular Atrophy Medicine Market Sales and Growth Rate Forecast Analysis (2022-2029) Figure Latin America Spinal Muscular Atrophy Medicine Market Revenue and Growth Rate Forecast Analysis (2022-2029) Figure Middle East and Africa Spinal Muscular Atrophy Medicine Market Sales and Growth Rate Forecast Analysis (2022-2029) Figure Middle East and Africa Spinal Muscular Atrophy Medicine Market Revenue and Growth Rate Forecast Analysis (2022-2029) Table Global Spinal Muscular Atrophy Medicine Market Sales Forecast, by Type Table Global Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast, by Type Table Global Spinal Muscular Atrophy Medicine Market Revenue Forecast, by Type Table Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast, by Type Table Global Spinal Muscular Atrophy Medicine Price Forecast, by Type Table Global Spinal Muscular Atrophy Medicine Market Consumption Forecast, by Application Table Global Spinal Muscular Atrophy Medicine Consumption Volume Market Share Forecast, by Application Table Global Spinal Muscular Atrophy Medicine Market Revenue Forecast, by Application Table Global Spinal Muscular Atrophy Medicine Revenue Market Share Forecast, by Application Table Global Spinal Muscular Atrophy Medicine Price Forecast, by Application